Abstract
This study uses publicly available data to estimate the amount of money that Medicaid lost due to the misclassification of brand-name epinephrine autoinjectors as generic products.
MeSH terms
-
Centers for Medicare and Medicaid Services, U.S.
-
Cost of Illness
-
Epinephrine / administration & dosage*
-
Epinephrine / economics
-
Health Expenditures / statistics & numerical data
-
Humans
-
Injections, Intramuscular / economics*
-
Injections, Intramuscular / instrumentation
-
Insurance, Health, Reimbursement / economics*
-
Insurance, Health, Reimbursement / statistics & numerical data
-
Managed Care Programs / economics
-
Medicaid / economics*
-
Medicaid / statistics & numerical data
-
United States